These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 36101669)

  • 41. CircTET1 Inhibits Retinoblastoma Progression via Targeting miR-492 and miR-494-3p through Wnt/β-catenin Signaling Pathway.
    Fu C; Wang S; Jin L; Zhang M; Li M
    Curr Eye Res; 2021 Jul; 46(7):978-987. PubMed ID: 33108919
    [No Abstract]   [Full Text] [Related]  

  • 42. microRNA-139-3p Inhibits Malignant Behaviors of Laryngeal Cancer Cells via the KDM5B/SOX2 Axis and the Wnt/β-Catenin Pathway.
    Ma Y; Chen Z; Yu G
    Cancer Manag Res; 2020; 12():9197-9209. PubMed ID: 33061611
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Downregulated KIF3B Induced by miR-605-3p Inhibits the Progression of Colon Cancer via Inactivating Wnt/
    Wang Q; Hao X; Xu G; Lv T
    J Oncol; 2021; 2021():5046981. PubMed ID: 34422048
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MicroRNA-142-3p Negatively Regulates Canonical Wnt Signaling Pathway.
    Hu T; Phiwpan K; Guo J; Zhang W; Guo J; Zhang Z; Zou M; Zhang X; Zhang J; Zhou X
    PLoS One; 2016; 11(6):e0158432. PubMed ID: 27348426
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hypoxia Activates SOX5/Wnt/β-Catenin Signaling by Suppressing MiR-338-3p in Gastric Cancer.
    Zheng JJ; Que QY; Xu HT; Luo DS; Sun Z; Ni JS; Que HF; Ma J; Wu D; Shi H
    Technol Cancer Res Treat; 2020; 19():1533033820905825. PubMed ID: 32216582
    [TBL] [Abstract][Full Text] [Related]  

  • 46. SP1-stimulated miR-545-3p inhibits osteogenesis via targeting LRP5-activated Wnt/beta-catenin signaling.
    Li L; Qiu X; Sun Y; Zhang N; Wang L
    Biochem Biophys Res Commun; 2019 Sep; 517(1):103-110. PubMed ID: 31327495
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MYPT1, regulated by miR-19b-3p inhibits the progression of non-small cell lung cancer via inhibiting the activation of wnt/β-catenin signaling.
    Wang Y; Wang L; Guo J; Zuo S; Wang Z; Hua S
    Life Sci; 2021 Aug; 278():119573. PubMed ID: 33964297
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MicroRNA-22-3p targeted regulating transcription factor 7-like 2 (TCF7L2) constrains the Wnt/β-catenin pathway and malignant behavior in osteosarcoma.
    Xue Y; Guo Y; Liu N; Meng X
    Bioengineered; 2022 Apr; 13(4):9135-9147. PubMed ID: 34753394
    [TBL] [Abstract][Full Text] [Related]  

  • 49. microRNA-19a-3p and microRNA-376c-3p Promote Hepatocellular Carcinoma Progression Through SOX6-Mediated Wnt/β-Catenin Signaling Pathway.
    Cao X; Zhang J; Apaer S; Yao G; Li T
    Int J Gen Med; 2021; 14():89-102. PubMed ID: 33469348
    [TBL] [Abstract][Full Text] [Related]  

  • 50. miR-324-3p promotes gastric cancer development by activating Smad4-mediated Wnt/beta-catenin signaling pathway.
    Sun GL; Li Z; Wang WZ; Chen Z; Zhang L; Li Q; Wei S; Li BW; Xu JH; Chen L; He ZY; Ying K; Zhang X; Xu H; Zhang DC; Xu ZK
    J Gastroenterol; 2018 Jun; 53(6):725-739. PubMed ID: 29103082
    [TBL] [Abstract][Full Text] [Related]  

  • 51. miR-363-3p induces EMT via the Wnt/β-catenin pathway in glioma cells by targeting CELF2.
    Fan B; Su B; Song G; Liu X; Yan Z; Wang S; Hu F; Yang J
    J Cell Mol Med; 2021 Nov; 25(22):10418-10429. PubMed ID: 34636136
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MiRNA-301b-3p induces proliferation and inhibits apoptosis in AML cells by targeting FOXF2 and regulating Wnt/β-catenin axis.
    Lu Y; Zhong L; Luo X; Liu C; Dan W; Chu X; Wan P; Zhang Z; Wang X; Liu Z; Liu B
    Mol Cell Probes; 2022 Jun; 63():101805. PubMed ID: 35259424
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Erratum: MicroRNA-769-3p inhibits tumor progression in glioma by suppressing ZEB2 and inhibiting the Wnt/β-catenin signaling pathway.
    Wang K; Yang S; Gao Y; Zhang C; Sui Q
    Oncol Lett; 2021 Mar; 21(3):228. PubMed ID: 33613717
    [TBL] [Abstract][Full Text] [Related]  

  • 54. miR-216a-3p inhibits osteogenic differentiation of human adipose-derived stem cells via Wnt3a in the Wnt/β-catenin signaling pathway.
    Liang D; Song G; Zhang Z
    Exp Ther Med; 2022 Apr; 23(4):309. PubMed ID: 35340869
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MicroRNA-367-3p overexpression represses the proliferation and invasion of cervical cancer cells through downregulation of SPAG5-mediated Wnt/β-catenin signalling.
    Yang T; Tian S; Wang L; Wang Y; Zhao J
    Clin Exp Pharmacol Physiol; 2020 Apr; 47(4):687-695. PubMed ID: 31792998
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Non-Coding RNA NEAT1/miR-214-3p Contribute to Doxorubicin Resistance of Urothelial Bladder Cancer Preliminary Through the Wnt/β-Catenin pathway [Retraction].
    Cancer Manag Res; 2022; 14():3525-3526. PubMed ID: 36579352
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MiR-449b-5p inhibits human glioblastoma cell proliferation by inactivating WNT2B/Wnt/β-catenin signaling pathway.
    Hou WZ; Chen XL; Qin LS; Xu ZJ; Liao GM; Chen D; Hu LJ; Mao ZM; -S Huang J; Yuan Q; Liao C; Yao QM
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5549-5557. PubMed ID: 32495889
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Downregulation of MicroRNA-455-3p Links to Proliferation and Drug Resistance of Pancreatic Cancer Cells via Targeting TAZ.
    Zhan T; Huang X; Tian X; Chen X; Ding Y; Luo H; Zhang Y
    Mol Ther Nucleic Acids; 2018 Mar; 10():215-226. PubMed ID: 29499934
    [TBL] [Abstract][Full Text] [Related]  

  • 59. LncRNA metastasis-associated lung adenocarcinoma transcript-1 promotes osteogenic differentiation of bone marrow stem cells and inhibits osteoclastic differentiation of Mø in osteoporosis via the miR-124-3p/IGF2BP1/Wnt/β-catenin axis.
    Li X
    J Tissue Eng Regen Med; 2022 Mar; 16(3):311-329. PubMed ID: 34962086
    [TBL] [Abstract][Full Text] [Related]  

  • 60. miR-199b-3p contributes to acquired resistance to cetuximab in colorectal cancer by targeting CRIM1 via Wnt/β-catenin signaling.
    Han H; Li Y; Qin W; Wang L; Yin H; Su B; Yuan X
    Cancer Cell Int; 2022 Jan; 22(1):42. PubMed ID: 35090460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.